Drug Methods for Arteficial Termination of Unwanted Pregnancy

1. Soon, Judith A., Dustin Costescu, and Edith Guilbert. “Medications Used in Evidence-Based Regimens for Medical Abortion: An Overview.” Journal of Obstetrics and Gynaecology Canada (2016).10.1016/j.jogc.2016.04.005Search in Google Scholar

2. Shuang-wei, X. I. A. N. G. “The Relationship between the Effect of Mifepriston and Misoprostol on Induction of Labor in 9~ 24 Week Pregnancy and Pregnancy Term.” JOURNAL OF FUJIAN MEDICAL UNIVERSITY (2000): S1.Search in Google Scholar

3. Gravanis, A., et al. “Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women.” The Journal of Clinical Endocrinology & Metabolism 60.1 (1985): 156-163.10.1210/jcem-60-1-156Search in Google Scholar

4. Kekkonen, Raimo, et al. “Pharmacokinetics of mifepristone after low oral doses.” Contraception 54.4 (1996): 229-234.10.1016/S0010-7824(96)00193-XSearch in Google Scholar

5. Peyron, Remi, et al. “Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.” New England Journal of Medicine 328.21 (1993): 1509-1513.10.1056/NEJM199305273282101Search in Google Scholar

6. Ledger, W. L., et al. “Inhibition of ovulation by low-dose mifepristone (RU 486).” Human Reproduction 7.7 (1992): 945-950.10.1093/oxfordjournals.humrep.a137776Search in Google Scholar

7. Batista, Marcelo C., et al. “Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.” American journal of obstetrics and gynecology 167.1 (1992): 60-65.10.1016/S0002-9378(11)91627-5Search in Google Scholar

8. Lähteenmäki, Pekka, et al. “Pharmacokinetics and metabolism of RU 486.” Journal of steroid biochemistry 27.4-6 (1987): 859-863.10.1016/0022-4731(87)90160-9Search in Google Scholar

9. Aubeny, E., and E-E. Baulieu. “Activité contragestive de l’association au RU486 d’une prostaglandine active par voie orale.” Comptes rendus de l’Académie des sciences. Serie 3, Sciences de la vie 312.11 (1991): 539-545.Search in Google Scholar

10. Norman, J. E., K. J. Thong, and D. T. Baird. “Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.” The lancet 338.8777 (1991): 1233-1236.10.1016/0140-6736(91)92102-8Search in Google Scholar

11. Zieman, Miriam, et al. “Absorption kinetics of misoprostol with oral or vaginal administration.” Obstetrics & Gynecology 90.1 (1997): 88-92.10.1016/S0029-7844(97)00111-7Search in Google Scholar

12. Yenuberi, Hilda, et al. “A randomised double-blind placebo-controlled trial comparing stepwise oral misoprostol with vaginal misoprostol for induction of labour.” Tropical doctor (2016): 0049475515624856.10.1177/004947551562485626787644Search in Google Scholar

13. Peyron, Remi, et al. “Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.” New England Journal of Medicine 328.21 (1993): 1509-1513.10.1056/NEJM199305273282101Search in Google Scholar

14. Spitz, Irving M., et al. “Early pregnancy termination with mifepristone and misoprostol in the United States.” New England Journal of Medicine 338.18 (1998): 1241-1247.10.1056/NEJM199804303381801Search in Google Scholar

15. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. “Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial.” Br J Obstet Gynaecol 107.4 (2000): 524-530.10.1111/j.1471-0528.2000.tb13273.xSearch in Google Scholar

16. Li, Cui-Lan, et al. “Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.” Human Reproduction (2015): dev239.10.1093/humrep/dev239Search in Google Scholar

17. McKinley, Carolyn, K. Joo Thong, and David T. Baird. “Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol.” Human reproduction 8.9 (1993): 1502-1505.10.1093/oxfordjournals.humrep.a138287Search in Google Scholar

18. Raymond, Elizabeth G., et al. “First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.” Contraception 87.1 (2013): 26-37.10.1016/j.contraception.2012.06.011Search in Google Scholar

19. Bouschbacher, L., et al. “[Association of mifepristone and misoprostol for the medical management of early pregnancy failure].” Gynecologie, obstetrique & fertilite 42.12 (2014): 832-837.10.1016/j.gyobfe.2014.10.004Search in Google Scholar

20. Schaff, Eric A., et al. “Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial.” Jama 284.15 (2000): 1948-1953.10.1001/jama.284.15.1948Search in Google Scholar

21. Smith, Patricio Sanhueza, et al. “Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.” Reproductive health matters 22.44 (2015): 75-8210.1016/S0968-8080(15)43825-XSearch in Google Scholar

22. El-Refaey, Hazem, et al. “Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.” New England Journal of Medicine 332.15 (1995): 983-987.10.1056/NEJM1995041333215027885426Search in Google Scholar

23. Creinin, Mitchell D., et al. “A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion.” Obstetrics & Gynecology 103.5, Part 1 (2004): 851-859.10.1097/01.AOG.0000124271.23499.84Search in Google Scholar

24. Peña, Melanie, et al. “Efficacy and acceptability of a mifepristone–misoprostol combined regimen for early induced abortion among women in Mexico City.” International Journal of Gynecology & Obstetrics 127.1 (2014): 82-85.10.1016/j.ijgo.2014.04.012Search in Google Scholar

25. Ashok, Premila W., et al. “Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases.” BJOG: An International Journal of Obstetrics & Gynaecology 109.11 (2002): 1281-1289.10.1046/j.1471-0528.2002.02156.xSearch in Google Scholar

26. Jiang, Wen-Xiao, et al. “Factors related to completeness of medical abortion with mifepristone and misoprostol.” Journal of the Chinese Medical Association (2016).Search in Google Scholar

27. Bartley, Julia, et al. “Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.” Contraception 62.6 (2000): 297-303.10.1016/S0010-7824(00)00187-6Search in Google Scholar

28. Colleselli, V., et al. “Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study.” Archives of Gynecology and Obstetrics 294.6 (2016): 1265-1272.10.1007/s00404-016-4179-6Search in Google Scholar

29. Hausknecht, Richard. “Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States.” Contraception 67.6 (2003): 463-465.10.1016/S0010-7824(03)00049-0Search in Google Scholar

30. Christin-Maitre, Sophie, Philippe Bouchard, and Irving M. Spitz. “Medical termination of pregnancy.” New England Journal of Medicine 342.13 (2000): 946-956.10.1056/NEJM200003303421307Search in Google Scholar

31. Li, Cui-Lan, Li-Ping Song, and Shi-Yan Tang. “Advance in Mifepristone Combined With Misoprostol For Ultra-Early Pregnancy Termination (Amenorrhea≤ 35 days).” (2016).Search in Google Scholar

32. Creinin, Mitchell D., et al. “A randomized trial comparing misoprostol three and seven days after methotrexate for early abortion.” American journal of obstetrics and gynecology 173.5 (1995): 1578-1584.10.1016/0002-9378(95)90652-5Search in Google Scholar

33. Wiebe, Ellen, et al. “Comparison of abortions induced by methotrexate or mifepristone followed by misoprostol.” Obstetrics & Gynecology 99.5, Part 1 (2002): 813-819.10.1016/S0029-7844(02)01944-0Search in Google Scholar

34. Norman, J. E., K. J. Thong, and D. T. Baird. “Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.” The lancet 338.8777 (1991): 1233-1236.10.1016/0140-6736(91)92102-8Search in Google Scholar

35. Carbonell, J. Li, et al. “The use of misoprostol for abortion at≤ 9 weeks’ gestation.” The European Journal of Contraception & Reproductive Health Care 2.3 (1997): 181-185.10.3109/13625189709167474Search in Google Scholar

36. Creinin, Mitchell D., et al. “A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion.” Contraception 59.1 (1999): 11-16.10.1016/S0010-7824(98)00142-5Search in Google Scholar

37. Carbonell, J. Li, et al. “Vaginal misoprostol for abortion at 10–13 weeks’ gestation.” The European Journal of Contraception & Reproductive Health Care 4.1 (1999): 35-40.10.3109/13625189909043478Search in Google Scholar

38. Esteve, JL Carbonell, et al. “Vaginal misoprostol for late first trimester abortion.” Contraception 57.5 (1998): 329-333.10.1016/S0010-7824(98)00037-7Search in Google Scholar

39. Ngai, Suk Wai, et al. “Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage.” Human Reproduction 16.7 (2001): 1493-1496.10.1093/humrep/16.7.149311425836Search in Google Scholar

40. Jain, John K., et al. “A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy.” Human reproduction 17.6 (2002): 1477-1482.10.1093/humrep/17.6.147712042265Search in Google Scholar

41. van den Berg, Joyce, et al. “Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.” European Journal of Obstetrics & Gynecology and Reproductive Biology 183 (2014): 16-1910.1016/j.ejogrb.2014.10.01025461345Search in Google Scholar

42. Dimitrijevic, Aleksandra, et al. “Endometrial thickness and beginning of bleeding as prospective markers for the risk of surgical intervention after intracervical application of misoprostol in early pregnancy failure.” HealthMED 6.4 (2012): 1394-1400Search in Google Scholar

43. Zivanovic A, Dimitrijevic A, Kastratovic T, Sorak M, Tanaskovic I. Endometrial thicknes as predictor of the effectiveness of intracervical misoprostol in early pregnancy failure. 11th ESC Congress, The Hague, The Netherlands 2010. Book of Abstracts P001 M34Search in Google Scholar

44. Dimitrijevic A,:,, Hirurške i medikamentozne metode arteficijlnog pobačaja”, Doktorska disertacija, Fakultet medicinskih nauka Univerziteta u Kragujevcu, 2010. godinaSearch in Google Scholar

45. Foster, Angel M., L. L. Wynn, and James Trussell. “Evidence of global demand for medication abortion information: An analysis of www.medicationabortion.com.” Contraception 89.3 (2014): 174-180.10.1016/j.contraception.2013.05.005388386924360644Search in Google Scholar

46. Vogel, Kristina I., et al. “Exploring Canadian women’s knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.” Contraception (2016).10.1016/j.contraception.2016.04.00827125893Search in Google Scholar

47. Beucher, G., et al. “[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].” Journal de gynecologie, obstetrique et biologie de la reproduction 43.2 (2014): 123-145Search in Google Scholar

48. Mahmood, Anila, Chandra Madhu Das, and Razia Mustafa Nusrat. “Medical Treatment of Missed Miscarriage before 24 Week of Gestation at Liaquat University Hospital.” Journal of Liaquat University of Medical & Health Sciences 15.1 (2016): 46-50.10.22442/jlumhs.161510463Search in Google Scholar